124 related articles for article (PubMed ID: 7769658)
21. A cell-type-specific transcription enhancer of type 16 human papillomavirus (HPV 16)-P97 promoter is defined with HPV-associated cellular events in human epithelial cell lines.
Taniguchi A; Kikuchi K; Nagata K; Yasumoto S
Virology; 1993 Aug; 195(2):500-10. PubMed ID: 8393236
[TBL] [Abstract][Full Text] [Related]
22. The 5' region of the human papillomavirus type 31 upstream regulatory region acts as an enhancer which augments viral early expression through the action of YY1.
Kanaya T; Kyo S; Laimins LA
Virology; 1997 Oct; 237(1):159-69. PubMed ID: 9344918
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules.
Cripe TP; Alderborn A; Anderson RD; Parkkinen S; Bergman P; Haugen TH; Pettersson U; Turek LP
New Biol; 1990 May; 2(5):450-63. PubMed ID: 1963084
[TBL] [Abstract][Full Text] [Related]
24. Oct-1 specifically binds the UEF4 site of the human AP1-regulated urokinase enhancer.
Palazzolo M; Berthelsen J; De Cesare D; Blasi F
Eur J Biochem; 2000 Sep; 267(17):5427-37. PubMed ID: 10951201
[TBL] [Abstract][Full Text] [Related]
25. An octamer-binding site is crucial for the activity of an enhancer active at the embryonic met-/mesencephalic junction.
Mihailescu D; Küry P; Monard D
Mech Dev; 1999 Jun; 84(1-2):55-67. PubMed ID: 10473120
[TBL] [Abstract][Full Text] [Related]
26. Transcription factors NFI and NFIII/oct-1 function independently, employing different mechanisms to enhance adenovirus DNA replication.
Mul YM; Verrijzer CP; van der Vliet PC
J Virol; 1990 Nov; 64(11):5510-8. PubMed ID: 2214023
[TBL] [Abstract][Full Text] [Related]
27. Reconstitution of T cell-specific transcription directed by composite NFAT/Oct elements.
Bert AG; Burrows J; Hawwari A; Vadas MA; Cockerill PN
J Immunol; 2000 Nov; 165(10):5646-55. PubMed ID: 11067921
[TBL] [Abstract][Full Text] [Related]
28. The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription.
Chong T; Apt D; Gloss B; Isa M; Bernard HU
J Virol; 1991 Nov; 65(11):5933-43. PubMed ID: 1656080
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of basal transcription from the mouse mammary tumor virus promoter by Oct proteins.
Kim MH; Peterson DO
J Virol; 1995 Aug; 69(8):4717-26. PubMed ID: 7609037
[TBL] [Abstract][Full Text] [Related]
30. The octamer binding site in the HPV16 regulatory region produces opposite effects on gene expression in cervical and non-cervical cells.
Morris PJ; Dent CL; Ring CJ; Latchman DS
Nucleic Acids Res; 1993 Feb; 21(4):1019-23. PubMed ID: 8383834
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region.
Butz K; Hoppe-Seyler F
J Virol; 1993 Nov; 67(11):6476-86. PubMed ID: 8411351
[TBL] [Abstract][Full Text] [Related]
32. Interactions of the Oct-1 POU subdomains with specific DNA sequences and with the HSV alpha-trans-activator protein.
Kristie TM; Sharp PA
Genes Dev; 1990 Dec; 4(12B):2383-96. PubMed ID: 1980658
[TBL] [Abstract][Full Text] [Related]
33. Oct-1 promoter region contains octamer sites and TAAT motifs recognized by Oct proteins.
Pankratova EV; Polanovsky OL
FEBS Lett; 1998 Apr; 426(1):81-5. PubMed ID: 9598983
[TBL] [Abstract][Full Text] [Related]
34. Genetic and biochemical analysis of cis regulatory elements within the keratinocyte enhancer region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle.
Sen E; Alam S; Meyers C
J Virol; 2004 Jan; 78(2):612-29. PubMed ID: 14694093
[TBL] [Abstract][Full Text] [Related]
35. Simian virus 40 (SV40) T-antigen transcriptional activation mediated through the Oct/SPH region of the SV40 late promoter.
Gruda MC; Alwine JC
J Virol; 1991 Jul; 65(7):3553-8. PubMed ID: 1645783
[TBL] [Abstract][Full Text] [Related]
36. Interaction of the bovine papillomavirus type 1 E2 transcriptional control protein with the viral enhancer: purification of the DNA-binding domain and analysis of its contact points with DNA.
Moskaluk CA; Bastia D
J Virol; 1988 Jun; 62(6):1925-31. PubMed ID: 2835497
[TBL] [Abstract][Full Text] [Related]
37. Concerted repression of an immunoglobulin heavy-chain enhancer, 3' alpha E(hs1,2).
Singh M; Birshtein BK
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4392-7. PubMed ID: 8633077
[TBL] [Abstract][Full Text] [Related]
38. Transcription factors Oct-1 and C/EBPbeta (CCAAT/enhancer-binding protein-beta) are involved in the glutamate/nitric oxide/cyclic-guanosine 5'-monophosphate-mediated repression of mediated repression of gonadotropin-releasing hormone gene expression.
Belsham DD; Mellon PL
Mol Endocrinol; 2000 Feb; 14(2):212-28. PubMed ID: 10674395
[TBL] [Abstract][Full Text] [Related]
39. A novel YY1-independent silencer represses the activity of the human papillomavirus type 16 enhancer.
O'Connor MJ; Stünkel W; Zimmermann H; Koh CH; Bernard HU
J Virol; 1998 Dec; 72(12):10083-92. PubMed ID: 9811748
[TBL] [Abstract][Full Text] [Related]
40. Regulation of the human papillomavirus type 11 E6 promoter by viral and host transcription factors in primary human keratinocytes.
Dollard SC; Broker TR; Chow LT
J Virol; 1993 Mar; 67(3):1721-6. PubMed ID: 8382318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
